Document Detail


Management of severe COPD.
MedLine Citation:
PMID:  15351196     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, and the burden of the disorder will continue to increase over the next 20 years despite medical intervention. Apart from smoking cessation, no approach or agent affects the rate of decline in lung function and progression of the disease. Especially in the later phase, COPD is a multicomponent disorder, and various integrated intervention strategies are needed as part of the optimum management programme. This seminar describes largely non-pharmacological interventions aimed at improving health status and function of disabled patients. Exacerbations become progressively more troublesome as baseline lung function declines, commonly necessitating hospital admission and associated with the development of acute respiratory failure.
Authors:
E F M Wouters
Related Documents :
20550756 - Psycho-educational interventions designed to prevent deployment-related psychological i...
17147756 - Evidence review on older people's views and experiences of falls prevention strategies.
18314086 - Perceptions of factors influencing healthful food consumption behavior in the lower mis...
10790476 - Controversies regarding definition of neonatal hypoglycemia: suggested operational thre...
12322996 - Online patient information.
1955576 - Experiences of a health team working in a new urban settlement area in istanbul.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Lancet     Volume:  364     ISSN:  1474-547X     ISO Abbreviation:  Lancet     Publication Date:    2004 Sep 4-10
Date Detail:
Created Date:  2004-09-07     Completed Date:  2004-09-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  England    
Other Details:
Languages:  eng     Pagination:  883-95     Citation Subset:  AIM; IM    
Affiliation:
Department of Respiratory Medicine, University Hospital Maastricht, 6229 HX Maastricht, Netherlands. e.wouters@lung.azm.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adrenergic beta-Agonists / therapeutic use
Edema / etiology,  physiopathology
Humans
Lung Transplantation
Pneumonectomy
Prognosis
Pulmonary Disease, Chronic Obstructive / complications,  physiopathology,  therapy*
Respiration, Artificial / methods
Respiratory Insufficiency / etiology,  therapy
Water-Electrolyte Imbalance / etiology,  physiopathology
Weight Loss
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and mo...
Next Document:  Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss?